Udai Kammula, MD

Director, Solid Tumor Cellular Immunotherapy Program Hillman Cancer Center
University of Pittsburgh Medical Center

Dr. Kammula is a surgical oncologist and tumor immunologist who conducts clinical and translational research focused on developing effective immunotherapies for patients with advanced cancer. He is the director of the Solid Tumor Cellular Immunotherapy Program at the University of Pittsburgh
Dr. Kammula received his B.A. from Johns Hopkins University and his M.D. from the University of Maryland. He completed his general surgery residency at the University of Chicago Hospitals and fellowships in surgical oncology in the Surgery Branch of the National Cancer Institute (NCI) and at Memorial Sloan-Kettering Cancer Center (MSKCC) in New York. Additional post-doctoral training in tumor immunology and cancer immunotherapy was completed in the Surgery Branch, NCI. Dr. Kammula was a senior investigator in the Surgery Branch, NCI between 2004 and 2017.

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Cell-based Therapies: CAR-T, TILS, PBMC

  Thursday, March 10, 2022
  3:43 PM – 4:03 PM CST